CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15,268 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00613314
NCT00613314N/ACompleted
CompareCT.gov

Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen (CENTER)

Boehringer Ingelheim·observational·Posted Feb 13, 2008·Updated May 26, 2014

In Brief

An observational study for Hypertension and Metabolic Syndrome X. Completed, enrolled 15,268 participants across 122 sites.

Detailed Summary

To determine the efficacy and safety of telmisartan-based treatment among patients with metabolic syndrome in actual setting in Philippines.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension, Metabolic Syndrome X
CountriesPhilippines
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 13, 2008
Enrollment StartJun 1, 2007
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 18.4 years ago